Clinical Benefit of Multiple Myeloma Drugs at Regulatory Approval in Brazil, Europe, and the USA: A Retrospective Cohort Study (2003-2024).
Saved in:
| Title: | Clinical Benefit of Multiple Myeloma Drugs at Regulatory Approval in Brazil, Europe, and the USA: A Retrospective Cohort Study (2003-2024). |
|---|---|
| Authors: | Rodrigues MA; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil., de Pádua CAM; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil., de Miranda Drummond PL; Fundação Ezequiel Dias - FUNED, Brazil, Belo Horizonte, Brazil., de Souza PHC; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil., Malta JS; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil., Reis AMM; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil. amreis@outlook.com. |
| Source: | Clinical drug investigation [Clin Drug Investig] 2026 Jun; Vol. 46 (6), pp. 641-653. Date of Electronic Publication: 2026 Apr 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42012573 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical Benefit of Multiple Myeloma Drugs at Regulatory Approval in Brazil, Europe, and the USA: A Retrospective Cohort Study (2003-2024). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rodrigues+MA%22">Rodrigues MA</searchLink>; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil.<br /><searchLink fieldCode="AU" term="%22de+Pádua+CAM%22">de Pádua CAM</searchLink>; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil.<br /><searchLink fieldCode="AU" term="%22de+Miranda+Drummond+PL%22">de Miranda Drummond PL</searchLink>; Fundação Ezequiel Dias - FUNED, Brazil, Belo Horizonte, Brazil.<br /><searchLink fieldCode="AU" term="%22de+Souza+PHC%22">de Souza PHC</searchLink>; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil.<br /><searchLink fieldCode="AU" term="%22Malta+JS%22">Malta JS</searchLink>; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil.<br /><searchLink fieldCode="AU" term="%22Reis+AMM%22">Reis AMM</searchLink>; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil. amreis@outlook.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2026 Jun; Vol. 46 (6), pp. 641-653. <i>Date of Electronic Publication: </i>2026 Apr 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1918 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42012573 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40261-026-01552-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 641 Titles: – TitleFull: Clinical Benefit of Multiple Myeloma Drugs at Regulatory Approval in Brazil, Europe, and the USA: A Retrospective Cohort Study (2003-2024). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rodrigues MA – PersonEntity: Name: NameFull: de Pádua CAM – PersonEntity: Name: NameFull: de Miranda Drummond PL – PersonEntity: Name: NameFull: de Souza PHC – PersonEntity: Name: NameFull: Malta JS – PersonEntity: Name: NameFull: Reis AMM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-1918 Numbering: – Type: volume Value: 46 – Type: issue Value: 6 Titles: – TitleFull: Clinical drug investigation Type: main |
| ResultId | 1 |